Semiquantitative Detection by Real-Time PCR ofAspergillus fumigatusin Bronchoalveolar Lavage Fluids and Tissue Biopsy Specimens from Patients with Invasive Aspergillosis
Open Access
- 1 September 2003
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (9) , 4304-4311
- https://doi.org/10.1128/jcm.41.9.4304-4311.2003
Abstract
A real-time PCR method was developed and used to detect Aspergillus fumigatus mitochondrial DNA (mtDNA) in bronchoalveolar lavage (BAL) fluids and tissue biopsy specimens. The analytical sensitivity of the assay was one A. fumigatus conidium per reaction, and the assay was linear at least over 4 orders of magnitude above the detection limit. BAL fluids from 66 immunocompromised patients at risk of invasive pulmonary aspergillosis (IPA) and 33 immunocompetent controls and tissue biopsy specimens from 10 immunocompromised patients were analyzed. The results were related to the clinical diagnosis established according to recently published consensus criteria. A. fumigatus mtDNA positivity was encountered in 16 of 81 (20%) BAL fluid specimens from patients at risk and 1 of 33 (3%) specimens from immunocompetent controls. PCRs were positive in six of seven, two of four, and four of five of the patients with proven, probable, and possible IPA, respectively, as well as in four patients at risk but without any other evidence of IPA. With qualitative detection, the diagnostic sensitivity of PCR was 73%, specificity was 93%, and predictive values of positive (PPV) and negative (NPV) results were 73 and 95%, respectively. Using a threshold cycle of A. fumigatus. Semiquantitative detection of A. fumigatus mtDNA in BAL fluid may be helpful in the diagnosis of IPA. PCR is well suited for the verification of the presence of A. fumigatus in tissue biopsy specimens.Keywords
This publication has 43 references indexed in Scilit:
- Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive AspergillosisJournal of Clinical Microbiology, 2003
- Development of a LightCycler PCR Assay for Detection and Quantification ofAspergillus fumigatusDNA in Clinical Samples from Neutropenic PatientsJournal of Clinical Microbiology, 2003
- Real-Time PCR Coupled with Automated DNA Extraction and Detection of Galactomannan Antigen in Serum by Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive AspergillosisJournal of Clinical Microbiology, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Detection ofAspergillusSpecies in Blood and Bronchoalveolar Lavage Samples from Immunocompromised Patients by Means of 2‐Step Polymerase Chain Reaction: Clinical ResultsClinical Infectious Diseases, 2001
- Detection of Aspergillus Species DNA by PCR in Bronchoalveolar Lavage FluidJournal of Clinical Microbiology, 2001
- Nucleic Acid Sequence-Based Amplification of Aspergillus RNA in Blood SamplesJournal of Clinical Microbiology, 2001
- Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropeniaBritish Journal of Haematology, 2000
- Aspergillus Antigen in Serum, Urine and Bronchoalveolar Lavage Specimens of Neutropenic Patients in Relation to Clinical OutcomeScandinavian Journal of Infectious Diseases, 2000
- Use of the Polymerase Chain Reaction and DNA Sequencing for Detection of Bartonella quintana in the Aortic Valve of a Patient with Culture-Negative Infective EndocarditisClinical Infectious Diseases, 1995